Merck & Co Inc
NYSE : MRK$145.95+1.92%Oct 16 close
Financials
A full-history view is not available for the cash flow statement yet. This is the statement exactly as one filing printed it.
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
USD · reported units. Click a value to inspect its source.
| Reported line item | Jan 1, 2026 to Jun 30, 2026 (current) | Jan 1, 2025 to Jun 30, 2025 |
|---|---|---|
| Statement of Cash Flows [Abstract] | ||
| Cash Flows from Operating Activities | ||
| Net (loss) income | ||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||
| Amortization | ||
| Depreciation | ||
| Income from investments in equity securities, net | ||
| Charges for research and development asset acquisitions | ||
| Deferred income taxes | ||
| Share-based compensation | ||
| Other | ||
| Net changes in assets and liabilities | ||
| Net Cash Provided by Operating Activities | ||
| Cash Flows from Investing Activities | ||
| Capital expenditures | ||
| Purchases of securities and other investments | ||
| Proceeds from sales of securities and other investments | ||
| Acquisition of Cidara Therapeutics, Inc., net of cash acquired | ||
| Acquisition of Terns Pharmaceuticals, Inc., net of cash acquired | ||
| Other | ||
| Net Cash Used in Investing Activities | ||
| Cash Flows from Financing Activities | ||
| Proceeds from term loan | ||
| Payments on term loan | ||
| Proceeds from issuance of debt | ||
| Payments on debt | ||
| Dividends paid to stockholders | ||
| Purchases of treasury stock | ||
| Proceeds from exercise of stock options | ||
| Other | ||
| Net Cash Used in Financing Activities | ||
| Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash | ||
| Net Decrease in Cash, Cash Equivalents and Restricted Cash | ||
| Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $125 and $76 at January 1, 2026 and 2025, respectively, included in Other current assets) | ||
| Cash, Cash Equivalents and Restricted Cash at End of Period (includes restricted cash of $42 and $66 at June 30, 2026 and 2025, respectively, included in Other current assets) |
30 line items · 2 reported periodsOriginal filing order · parentheses indicate negative amounts
Each column reflects this filing’s presentation. Original line items and period dates are preserved.